Predictive value of serum homocysteine and potassium ion for short-term prognosis of patients with acute cerebral infarction following intravenous thrombolysis with recombinant tissue plasminogen activator [0.03%]
重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死患者短期预后的血清同型半胱氨酸及钾离子预测价值
Lingen Pang,Yongan Sun,Mingli He et al.
Lingen Pang et al.
Objective: This study evaluated the predictive value of serum homocysteine (HcY) and potassium ion (K+) for short-term prognosis of patients with acute cerebral infarction (ACI) undergoing intravenous thrombolysis with re...
Type 3 von Willebrand disease in Ethiopia: a comprehensive literature review and report of the first three cases [0.03%]
埃塞俄比亚的von Willebrand疾病的第三型：全面文献回顾及首三病例报告
Gashaw Arega,Elezer Berhanu Zewde,Abdulkadir Mohamed Said et al.
Gashaw Arega et al.
Type 3 von Willebrand disease (VWD) is the rarest and most severe form of VWD, resulting from a complete loss of function of the von Willebrand factor (VWF). This disease presents bleeding symptoms that are characteristic of primary hemosta...
Association of the p.Phe155del mutation in SERPINC1 with changed antithrombin function and increased risk of venous thromboembolism: clinical and functional observations [0.03%]
SERPINC1基因p.Phe155del突变与抗凝血酶功能改变及静脉血栓栓塞风险增加的临床和功能观察
Jing Lu,Zuoyu Qin,Yining Lan et al.
Jing Lu et al.
Introduction: Antithrombin (AT) deficiency, often caused by mutations in the SERPINC1 gene, is a well-established risk factor for venous thromboembolism (VTE), which can lead to serious complications such as deep vein thr...
Associations between rivaroxaban dose, gut microbiota, and coagulation parameters in a rat model [0.03%]
利伐沙班剂量、肠道微生物群和凝血参数在大鼠模型中的关联研究
Yuanyuan Liu,Yi Zhang,Yang Yang et al.
Yuanyuan Liu et al.
Antiphospholipid syndrome presents with aortic thrombosis and central venous catheter-related thrombosis: a case report [0.03%]
抗磷脂综合征合并主动脉血栓及中心静脉导管相关性血栓形成1例报告
Yujiao Chen,Dongjing Li,Yinghong Su et al.
Yujiao Chen et al.
Background: Antiphospholipid syndrome (APS) is a prothrombotic autoimmune disorder in which perioperative factors-particularly cardiopulmonary bypass-may amplify hypercoagulability. Evidence and consensus guidance for APS...
Genetic and clinical characterization of two families with severe venous thromboembolism due to nonsense mutations in the SERPINC1 gene [0.03%]
SERPINC1基因无义突变所致严重静脉血栓栓塞症家系的遗传及临床特征分析
Xuqian Wei,Weibin Chen,Jian Zhang et al.
Xuqian Wei et al.
Antithrombin (AT) III is a key physiological anticoagulant, and its hereditary deficiency represents one of the most severe forms of inherited thrombophilia. However, as a rare disorder, AT III deficiency is frequently underdiagnosed due to...
Efficacy and safety of anticoagulation dose reduction for venous thromboembolism prophylaxis in low body weight patients: a systematic review and meta-analysis [0.03%]
低体重患者静脉血栓栓塞预防的抗凝剂量减少的有效性和安全性：系统评价和meta分析
Ian Gabriel Alparaque Juyad,Rochelle Ivy A Cion,Genquen Philip Carado et al.
Ian Gabriel Alparaque Juyad et al.
The correlation of lupus anticoagulant and anticardiolipin antibodies with hematological parameters and clinical findings in sickle cell disease at steady state phase [0.03%]
卢匹抗凝物和抗心磷脂抗体与稳定期镰形细胞性贫血的血液学参数及临床发现的相关性研究
Mohammed Aw Almorish,Ahmed M E Elkhalifa,Moataz Mohamedalhasan Ali et al.
Mohammed Aw Almorish et al.
Background: Current therapeutic interventions for Sickle Cell Disease (SCD) have improved patient survival; however, the clinical determinants of elevated autoantibody prevalence and related complications in patients with...
Long-term patency of the transjugular intrahepatic portosystemic shunt for portal and superior mesenteric vein thrombosis [0.03%]
经颈静脉肝内门体分流术治疗门静脉和肠系膜上静脉血栓形成的长期通畅性
Junyang Luo,Churen Zhou,Yanyang Zhang et al.
Junyang Luo et al.
A retrospective study on the clinical outcomes of endovascular intervention treatment for inferior vena cava filter thrombosis [0.03%]
下腔静脉滤器血栓置入血管内介入治疗的临床疗效回顾性研究
Shiqiang Liao,Shuming Shi,Chuanyong Li et al.
Shiqiang Liao et al.